Basic Information
| LncRNA/CircRNA Name | FBXL19-AS1 |
| Synonyms | NA |
| Region | GRCh38_16:30919319-30923269 |
| Ensemble | ENSG00000260852 |
| Refseq | NR_024348 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | breast cancer |
| ICD-0-3 | C50 |
| Methods | qPCR, Luciferase reporter assay, RIP, Western blot |
| Sample | BC tissues,cell lines(MDA-MB-231, ZR-75-1, MCF-7, BT-549, MDA-MB-468, Bcap37,T47D) |
| Expression Pattern | up-regulated |
| Function Description | QRT-PCR showed that FBXL19-AS1 expression was significantly up-regulated in BC tissues compared with ANT |
| Pubmed ID | 30886065 |
| Year | 2019 |
| Title | LncRNA FBXL19-AS1 promotes breast cancer cells proliferation and invasion via acting as a molecular sponge to miR-718. |
External Links
| Links for FBXL19-AS1 | GenBank HGNC NONCODE |
| Links for breast cancer | OMIM COSMIC |